JW Shinyak

067290 · KOSDAQ · Health Care · SMALL CAP

Provisional Q1 2026 results.

JW Shinyak filed provisional (unaudited) separate results for Q1 2026: revenue of US$14.4M (+8.8% year on year), operating profit of US$1.94M (+332.1% year on year) and net income of US$1.79M (−68.9% year on year).

Earnings(Operating results (preliminary) (fair disclosure))· FILED 2026-05-13· RCEPT 20260513900897

US$14.4MRevenue
+8.8%Revenue vs a year earlier
US$1.94MOperating profit

Converted at 1 USD ≈ ₩1,489.84 (filing-date rate, 2026-05-13 close)

What happened

JW Shinyak filed provisional (unaudited) separate results for Q1 2026: revenue of US$14.4M (+8.8% year on year), operating profit of US$1.94M (+332.1% year on year) and net income of US$1.79M (−68.9% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$14.4M
Revenue vs a year earlier+8.8%
Operating profitUS$1.94M
Net incomeUS$1.79M
PeriodQ1 2026 (separate)
Filed2026-05-13, Operating results (preliminary) (fair disclosure)
SourceDART rcept 20260513900897 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-13 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.